| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.06▲ | 10.01▲ | 9.98▲ | 9.76▲ | 9.59▲ |
| MA10 | 10.03▲ | 9.94▲ | 9.96▲ | 9.59▲ | 8.70▲ |
| MA20 | 10.00▲ | 9.96▲ | 9.85▲ | 9.57▲ | 8.05▲ |
| MA50 | 9.94▲ | 9.76▲ | 9.58▲ | 8.60▲ | 11.71▼ |
| MA100 | 9.94▲ | 9.55▲ | 9.57▲ | 8.03▲ | 22.38▼ |
| MA200 | 9.88▲ | 9.56▲ | 9.24▲ | 9.66▲ | 30.83▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | 0.002▲ | 0.009▲ | -0.011▼ | 0.655▲ |
| RSI | 77.703▲ | 68.549▲ | 70.881▲ | 66.458▲ | 55.279▲ |
| STOCH | 95.379▲ | 74.669 | 57.987 | 60.017 | 84.620▲ |
| WILL %R | 0.000▲ | 0.000▲ | -7.692▲ | -10.261▲ | -3.667▲ |
| CCI | 194.924▲ | 240.223▲ | 190.034▲ | 160.252▲ | 118.442▲ |
|
Friday, October 31, 2025 10:55 PM
Oct. 05, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced positive ...
|
|
Thursday, October 30, 2025 05:00 PM
However, on October 28, TR | OpenAI – 4o reiterated a Hold rating on Arvinas Holding Company (NASDAQ: ARVN). The company has a one-year high of $28.83 and a one-year low of $5.90. Currently, Arvinas ...
|
|
Wednesday, October 29, 2025 04:11 AM
Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review financial results ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/10/25 | 9.99 | 10.14 | 9.80 | 10.14 | 2,228,972 |
| 30/10/25 | 9.88 | 10.1762 | 9.71 | 9.93 | 2,758,745 |
| 29/10/25 | 9.41 | 9.635 | 9.40 | 9.59 | 2,734,740 |
| 28/10/25 | 9.57 | 9.62 | 9.39 | 9.50 | 2,241,119 |
| 27/10/25 | 9.30 | 9.68 | 9.25 | 9.65 | 1,763,102 |
| 24/10/25 | 9.25 | 9.55 | 9.09 | 9.21 | 3,459,584 |
| 23/10/25 | 9.32 | 9.375 | 9.01 | 9.16 | 3,849,142 |
| 22/10/25 | 9.65 | 9.8499 | 9.195 | 9.31 | 2,310,868 |
| 21/10/25 | 9.72 | 9.97 | 9.61 | 9.66 | 1,603,795 |
| 20/10/25 | 9.62 | 9.82 | 9.53 | 9.72 | 1,844,178 |
|
|
||||
|
|
||||
|
|